neuropeptide comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-07-20. Numbers and descriptions here follow the published literature rather than marketing material.
Russian regulatory authorities approved the peptide for nasal administration, and it remains listed in the national pharmacopoeia under several trade names. Documented indications include acute ischemic stroke, transient ischemic attacks, traumatic brain injury, and certain ophthalmological and neurological conditions. Physicians also prescribe it for cognitive complaints in older patients, although the evidence base for that use is thinner. Outside Russia and a few neighboring states, the substance is not an approved medicine and is sold instead as a research chemical.
Later generations of the molecule include an N-acetylated form and an amidated form, both marketed online alongside the parent peptide. These variants differ in terminal chemistry and stability, and they are frequently discussed in the same breath even though they have not been compared in controlled trials. Supply outside formal healthcare systems comes largely from laboratories that synthesize peptides to order. Purity and identity of these materials vary widely, and no single body oversees the international trade.
Semax is a synthetic heptapeptide whose sequence is Met-Glu-His-Phe-Pro-Gly-Pro. It was developed as a fragment analog of adrenocorticotropic hormone, modeled specifically on the ACTH(4-10) region. The first four residues reproduce that fragment, while a Pro-Gly-Pro tripeptide is appended at the C-terminus. Work on the compound originated in Russia, where it entered clinical use as an intranasal preparation. Its sequence places it among short regulatory peptides studied for effects on the central nervous system rather than on the adrenal axis.
The C-terminal Pro-Gly-Pro extension is not incidental. Proline-rich tails are known to resist several common peptidases, and the published literature attributes the longer half-life of Semax, relative to unmodified ACTH fragments, to this feature. The modification also removes the melanocyte-stimulating and corticosteroidogenic activity that characterizes longer ACTH-derived sequences. Because the molecule is small and hydrophilic, it is typically formulated as an aqueous solution for intranasal or parenteral delivery. Acetylation or amidation at the termini appears in closely related research peptides and shifts the mass by a fixed increment.
Reported pharmacological work centers on neurotrophic signaling, including changes in BDNF and NGF expression in hippocampal tissue in animal models. Human data come largely from studies conducted in Russia, and how well those results generalize to other populations remains an open question. Regulatory status differs sharply by jurisdiction: Semax is a registered prescription medicine in Russia, while it holds no approved marketing status in the United States or the European Union. Outside such jurisdictions it is generally handled as a research chemical, which affects both documentation and quality expectations.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic heptapeptide | Analog of an ACTH fragment |
| Amino acid length | Seven residues | Met-Glu-His-Phe-Pro-Gly-Pro |
| Origin | Moscow, 1980s | Institute of Molecular Genetics |
| Approved regions | Russia and some neighboring states | Not cleared in Western markets |
| Common trade names | Multiple national brands | Sold as a nasal formulation |
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. Its design combines the ACTH(4-7) core fragment with a C-terminal Pro-Gly-Pro extension, a modification intended to improve stability and prolong activity. The molecule is hydrophilic, carries no lipid chains or glycosylation, and has a theoretical mass just over 810 daltons in its free form. All seven residues are proteinogenic amino acids, so no non-natural building blocks appear in the backbone. A free N-terminal methionine and C-terminal proline define the unmodified parent peptide.
The compound was developed during the 1980s at the Institute of Molecular Genetics in Moscow as part of research on fragments of adrenocorticotropic hormone. Early work examined short ACTH-derived sequences that retained neurotrophic effects while lacking the endocrine activity of the full hormone. Semax entered clinical use in Russia during the 1990s, where it received registration for several neurological indications. Outside that region it remained primarily a laboratory research material rather than an approved therapeutic. English-language literature on it grew more slowly and frequently cited the original Russian studies.
Terminology around the compound varies by source. It appears in catalogues and papers as Semax, as the heptapeptide ACTH(4-7)-Pro-Gly-Pro, and under various alphanumeric laboratory codes used by individual suppliers. These names refer to the same sequence but may imply different salt forms, purity grades, or counter-ions. Peptide databases usually list the free base mass, while product descriptions sometimes report acetate or trifluoroacetate salts with a different formula weight. Because naming conventions for research peptides are not standardised across vendors, checking the declared sequence and measured mass is more reliable than relying on a trade name alone.
The compound was developed in the 1980s at the Institute of Molecular Genetics in Moscow, where it emerged from research on short ACTH fragments and their effects on the central nervous system. Russian pharmaceutical listings describe it as a nootropic and neuroprotective agent, most often formulated as nasal drops. It is not a marketed medicine in the United States or the European Union, and no pharmacopoeial monograph covers it. Consequently, most published clinical experience with the substance originates from a small number of research centres, mainly in Russia and neighbouring countries.
Pharmacological accounts link semax to melanocortin signalling and to modulation of neurotrophic factor expression, particularly brain-derived neurotrophic factor and nerve growth factor. Much of this evidence comes from rodent studies using intranasal delivery, a route chosen because it allows peptides to reach the central nervous system with limited systemic exposure. Whether the same mechanisms operate in humans at comparable magnitude remains an open question. The precise receptor or receptors responsible for the reported behavioural and neuroprotective effects have not been conclusively identified.
Specialized CaM kinases, such as the myosin light chain kinase that phosphorylates myosin, causing smooth muscles to contract. Multifunctional CaM kinases, such as the four isozymes of CaM kinase II, which play a role in neurotransmitter secretion, transcription factor regulation, and glycogen metabolism.
== Early life and background == Alexander Zverev was born on 20 April 1997 in Hamburg, Germany, to Russian parents Irina Zvereva and Alexander Zverev Sr. His older brother, Mischa, born nearly a decade earlier, was also a professional tennis player. Both of his parents were professional tennis players for the Soviet Union. His father, who ranked as high as No. 175 in the world, became the top-ranked men's player nationally, while his mother was the fourth-highest-ranked women's player in the Soviet Union. They both moved from Sochi to the capital to train at the CSKA Moscow military-run tennis club. The Soviet government often restricted their players from competing outside the country, an impediment that limited how high either of Alexander's parents could rise in the world rankings. With the collapse of the Soviet Union imminent, Irina went to Germany to compete at a tournament in 1990, with her husband accompanying as her coach. While in Germany, they were offered jobs as tennis instructors. After initially declining, they accepted an offer to work at the Uhlenhorster Hockey Club in Hamburg the following year and ended up settling in the country. Zverev, known in his family as Sascha (the Russian-language diminutive for Alexander), started playing tennis at the age of three. Since he began playing tennis at a very young age, he has said, "One day, when I was, I think, one year and five months old, I just picked up a little racket and I was starting to push the ball all over our apartment, and since then, they took me out on the court.
The Zaporozhian Sich had its own authorities, its own "Lower" Zaporozhian Host, and its own land. In 1775, the Lower Dnieper Zaporozhian Host was destroyed. Later, its high-ranking Cossack leaders were exiled to Siberia, its last chief, Petro Kalnyshevsky, becoming a prisoner of the Solovetsky Islands. Some Cossacks moved to the Danube Delta region, where they established a new sich under Ottoman rule. To prevent further defection of Cossacks, the Russian government restored the special Cossack status of the majority of Zaporozhian Cossacks. This allowed them to unite in the Host of Loyal Zaporozhians, and later to reorganize into other hosts, of which the Black Sea Host was most important. Because of land scarcity resulting from the distribution of Zaporozhian Sich lands among landlords, they eventually moved on to the Kuban region. The majority of Danubian Sich Cossacks moved first to the Azov region in 1828, and later joined other former Zaporozhian Cossacks in the Kuban region. Groups were generally identified by faith rather than language in that period, and most descendants of Zaporozhian Cossacks in the Kuban region are bilingual, speaking both Russian and Balachka, the local Kuban dialect of central Ukrainian. Their folklore is largely Ukrainian. The predominant view of ethnologists and historians is that its origins lie in the common culture dating back to the Black Sea Cossacks.
Sources: en.wikipedia.org
=== Retail sale of sauces === In the spring of 2020, Chick-fil-A test-trialed the sale of two of their dipping sauces at some supermarkets in Florida, with all profits earmarked for a scholarship fund for the company's store-level employees. The trial was considered successful, and distribution was expanded nationwide by 2021. Two more sauces were added in 2023. In October 2022, the company trialed expansion of the program to include its salad dressings in the Cincinnati metropolitan area and in parts of Tennessee, and expanded nationwide in spring 2023. In January 2025, Chick-fil-A announced plans to centralize its lemonade production by moving it from its restaurant locations to a single, automated facility in Santa Clarita, California. This new plant is capable of processing between 30 and 35 truckloads of lemons daily, with each truckload containing 50,000 pounds of lemons.
Their mission, in their words "for the purpose of mutual aid in cases of sickness, accident and death of its members or their families". In 1923 it had 8,000 members in 60 subordinate societies; that year it had a capital of over $500,000, with a further $100,000 in sick benefit funds held by local societies. All policy decisions are determined by a "Central Society" made up of the officers, founders, and representatives of the subordinate lodges. A central society meets at stated intervals to elect officers to administer the group and make needed changes. Membership is open to men 18–50, of good moral character who have passed medical exams, regardless of religious or political creeds. Germania stated that it "is not a secret society. No pass-words or grips feature its work. In fact, any man is welcome to join its meetings." German Order of Harugari Greater Beneficial Union of Pittsburgh - Incorporated April 14, 1892 in Allegheny County, Pennsylvania, as the Deutscher Unter-stuetzungs-Bund, within a month had 243 members in 6 districts. Began the periodical, Union Reporter, the next year, now known as GBU Reporter. Rituals include the candidate signing an application and the president of the local lodge giving an address about the privileges of membership and how one should enter the lodge. Union claimed to be non-sectarian and had no secrets; open to all "well-meaning persons"; non-members accompanied by members allowed at meeting.
==== B. Aesthetics of the nose – nasal subunits and nasal segments ==== To plan, map, and execute the surgical correction of a nasal defect or deformity, the structure of the external nose is divided into nine aesthetic nasal subunits, and six aesthetic nasal segments, which provide the plastic surgeon with the measures for determining the size, extent, and topographic locale of the nasal defect or deformity.
Sources: en.wikipedia.org
==== Wound healing ==== High dose aspirin treatment (which inhibits cyclooxygenases-1 and -2 to block their production of 12-HHT), thromboxane synthase knockout, and BLT2 receptor knockout, but not TXA2 receptor knockout, impair keratinocyte-based re-epithelialization and thereby closure of experimentally induced wounds in mice. A synthetic BLT2 receptor agonist accelerates wound closure not only in this mouse model but also in the db/db mouse model of obesity, diabetes, and dyslipidemia due to leptin receptor deficiency. 12-HHT accumulated in the wounds of the former mouse model. Companion studies using an in vitro scratch test assay indicated that 12-HHT stimulated human and mouse keratinocyte migration by a BLT2 receptor-dependent mechanism that involved the production of tumor necrosis factor α and metalloproteinases. These results indicate that the 12-HHT/BLT2 receptor axis is a critical contributor to wound healing in mice and possibly humans. The axis operates by recruiting the movement of keratinocytes to close the wound. This mechanism may underlie the suppression of wound healing that accompanies the high dose intake of aspirin and, based on mouse studies, other non-steroidal anti-inflammatory agents (NSAIDs) in humans. Synthetic BLT2 agonists may be useful for speeding the healing of chronic ulcerative wounds, particularly in patients with, for example diabetics, that have impaired wound healing.
== History == Native American cultivators who first domesticated corn (maize) prepared it by nixtamalization, in which the grain is treated with a solution of alkali such as lime. Nixtamalization makes the niacin nutritionally available and prevents pellagra. When maize was cultivated worldwide, and eaten as a staple without nixtamalization, pellagra became common. Pellagra was first described for its dermatological effect in Spain in 1735 by Gaspar Casal. He explained that the disease causes dermatitis in exposed skin areas such as hands, feet, and neck and that the origin of the disease is poor diet and atmospheric influences. His work published in 1762 by his friend Juan Sevillano was titled Historia Natural y Medicina del Principado de Asturias or Natural and Medical History of the Principality of Asturias (1762). This led to the disease being known as "Asturian leprosy", and it is recognized as the first modern pathological description of a syndrome. It was an endemic disease in northern Italy, where it was named, from Lombard, by Francesco Frapolli of Milan (see #Etymology). With pellagra affecting over 100,000 people in Italy by the 1880s, debates raged as to how to classify the disease (as a form of scurvy, elephantiasis, or as something new) and over its causation. In the 19th century, Roussel started a campaign in France to restrict consumption of maize and eradicated the disease in France, but it remained endemic in many rural areas of Europe.
=== Imaging === The SBP-Tag will also bind to streptavidin or streptavidin reagents in solution. Applications of these engineered associations include the visualization of specific proteins within living cells, monitoring of the kinetics of the translation of individual proteins in an in vitro translation system, control of the integration of a multi-spanning membrane protein into the endoplasmic reticulum by fusing the SBP-Tag to the N-terminal translocation sequence and then halting integration with streptavidin and restarting integration with biotin. Fluorescent streptavidin reagents (e.g. streptavidin-HRP) can be used to visualize the SBP-tag by immunoblotting of SDS-PAGE. Additionally, antibodies to the SBP-tag are available commercially.
Plant fruit: the fleshy nutritious part of plants that animal dispense by eating independently came about in flowering plants and in some gymnosperms like: ginkgo and cycads. Water transport systems, like vascular plant systems, with water conducting vessels, independently came about in horsetails, club mosses, ferns, and gymnosperms. Wind pollination independently came about in pine trees, grasses, and wind pollinated flower. Wind dispersal of seeds independently came about in dandelions, milkweed, cottonwood trees, and others tufted seeds like, Impatiens sivarajanii, all adapted for wind dispersal. Hallucinogenic toxins independently came about in: peyotecactus, Ayahuasca vine, some fungi like psilocybin mushroom. Plant toxins independently came about in: solauricine, daphnin, tinyatoxin, ledol, protoanemonin, lotaustralin, chaconine, persin and more. Venus flytrap sea anemone is an animal and the Venus flytrap is a plant. Both look and act the same. Digestive enzymes independently came about in carnivorous plants and animals.
Sources: en.wikipedia.org
It originated at the Institute of Molecular Genetics in Moscow during the 1980s. The work was carried out by a Russian research group that specialized in peptide neuropharmacology.
It is registered as a medicine in Russia and has been used clinically there for decades. No regulatory agency in Western Europe or North America has approved it for any indication.
Semax corresponds to the four-to-ten fragment of adrenocorticotropic hormone. Because it omits the first three residues, it lacks the adrenal-stimulating action of the full hormone.
The sequence is Met-Glu-His-Phe-Pro-Gly-Pro, a seven-residue peptide. The first four residues correspond to the ACTH(4-10) fragment, and Pro-Gly-Pro is added at the C-terminus. N-acetylated versions also appear in the literature and differ in mass.